IdentificationGeneric Name(+)-Rutamarin alcoholDrugBank Accession NumberDB02205BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (+)-Rutamarin alcohol (DB02205)× CloseWeightAverage: 314.3756 Monoisotopic: 314.151809192 Chemical FormulaC19H22O4Synonyms(+)-ChalepinPharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUGlyceraldehyde-3-phosphate dehydrogenase, testis-specificNot AvailableHumansUGlyceraldehyde-3-phosphate dehydrogenase, glycosomalNot AvailableTrypanosoma cruziAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as psoralens. These are organic compounds containing a psoralen moiety, which consists of a furan fused to a chromenone to for 7H-furo[3,2-g]chromen-7-one.KingdomOrganic compoundsSuper ClassPhenylpropanoids and polyketidesClassCoumarins and derivativesSub ClassFuranocoumarinsDirect ParentPsoralensAlternative Parents1-benzopyrans / Coumarans / Pyranones and derivatives / Alkyl aryl ethers / Benzenoids / Tertiary alcohols / Heteroaromatic compounds / Lactones / Oxacyclic compounds / Organic oxides / Hydrocarbon derivatives


 show 1 moreSubstituents1-benzopyran / Alcohol / Alkyl aryl ether / Aromatic heteropolycyclic compound / Benzenoid / Benzopyran / Coumaran / Ether / Heteroaromatic compound / Hydrocarbon derivative / Lactone / Organic oxide / Organic oxygen compound / Organoheterocyclic compound / Organooxygen compound / Oxacycle / Psoralen / Pyran / Pyranone / Tertiary alcohol


 show 10 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIIV0632559ODCAS number14755-47-6InChI KeyJCDLLLXYAICSQV-INIZCTEOSA-NInChIInChI=1S/C19H22O4/c1-6-18(2,3)13-8-11-7-12-9-16(19(4,5)21)22-14(12)10-15(11)23-17(13)20/h6-8,10,16,21H,1,9H2,2-5H3/t16-/m0/s1IUPAC Name(2S)-2-(2-hydroxypropan-2-yl)-6-(2-methylbut-3-en-2-yl)-2H,3H,7H-furo[3,2-g]chromen-7-oneSMILESCC(C)(O)[C@@H]1CC2=C(O1)C=C1OC(=O)C(=CC1=C2)C(C)(C)C=CReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound5287846PubChem Substance46505661ChemSpider4450136BindingDB50220736ChEMBLCHEMBL1231470ZINCZINC000000898293PDBe LigandBRZPDB Entries1k3tClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.022 mg/mLALOGPSlogP3.54ALOGPSlogP3.3ChemaxonlogS-4.2ALOGPSpKa (Strongest Acidic)14.3ChemaxonpKa (Strongest Basic)-3.1ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count3ChemaxonHydrogen Donor Count1ChemaxonPolar Surface Area55.76 Å2ChemaxonRotatable Bond Count3ChemaxonRefractivity88.97 m3·mol-1ChemaxonPolarizability35.05 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.987Blood Brain Barrier+0.8052Caco-2 permeable-0.5661P-glycoprotein substrateSubstrate0.659P-glycoprotein inhibitor IInhibitor0.7482P-glycoprotein inhibitor IINon-inhibitor0.9353Renal organic cation transporterNon-inhibitor0.8936CYP450 2C9 substrateNon-substrate0.7799CYP450 2D6 substrateNon-substrate0.8524CYP450 3A4 substrateSubstrate0.5817CYP450 1A2 substrateNon-inhibitor0.6271CYP450 2C9 inhibitorNon-inhibitor0.8069CYP450 2D6 inhibitorNon-inhibitor0.894CYP450 2C19 inhibitorNon-inhibitor0.6504CYP450 3A4 inhibitorNon-inhibitor0.6074CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8342Ames testAMES toxic0.9107CarcinogenicityNon-carcinogens0.9325BiodegradationNot ready biodegradable0.9911Rat acute toxicity2.8967 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9902hERG inhibition (predictor II)Non-inhibitor0.9669  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableMS/MS Spectrum - , positiveLC-MS/MSsplash10-06di-0493000000-23d9876faa4360f0eb2dTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Glyceraldehyde-3-phosphate dehydrogenase, testis-specificKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionNadp bindingSpecific FunctionMay play an important role in regulating the switch between different pathways for energy production during spermiogenesis and in the spermatozoon. Required for sperm motility and male fertility (B...Gene NameGAPDHSUniprot IDO14556Uniprot NameGlyceraldehyde-3-phosphate dehydrogenase, testis-specificMolecular Weight44500.835 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] Binding Properties×PropertyMeasurementpHTemperature (°C)ReferencesIC 50 (nM)64000N/AN/AA29869


 Details


 Binding Properties2. Glyceraldehyde-3-phosphate dehydrogenase, glycosomalKindProteinOrganismTrypanosoma cruziPharmacological actionUnknownGeneral FunctionNadp bindingSpecific FunctionNot AvailableGene NameNot AvailableUniprot IDP22513Uniprot NameGlyceraldehyde-3-phosphate dehydrogenase, glycosomalMolecular Weight39060.3 DaReferencesOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article] Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 